title: Penetration pathways induced by low-frequency sonophoresis with physical and chemical enhancers: iron oxide nanoparticles versus lanthanum nitrates.
abstract: Low-frequency sonophoresis (LFS) has been shown to disrupt the structure of stratum corneum (SC) lipid bilayers and enhance SC permeability. In this study, we examined the penetration pathway of lanthanum nitrate (LaNO(3)) tracer in viable epidermis after combined treatment of LFS and tape stripping (TS), as a physical enhancer, or oleic acid (OA) application, as a chemical enhancer, using transmission electron microscopy (TEM). As a positive control, we visualized the passive diffusion pathway of LaNO(3) and iron oxide (Fe(3)O(4)) nanoparticles after the incision of hairless mouse skin. Next, we applied LFS immediately after TS or OA application and visualized the penetration pathway of LaNO(3). Each treatment showed restricted penetration to the SC-stratum granulosum (SG) interface or upper SG layer. However, the additional application of LFS induced diffuse intracellular distribution of LaNO(3) throughout the viable epidermis. Quantitative analysis also revealed that combined treatment significantly increases LaNO(3) penetration into viable epidermis when compared with each treatment. Our ultrastructural findings show the synergistic effect of LFS and TS or OA application on transdermal drug delivery. We also found that this combined treatment enhances the penetration of LaNO(3) through the viable epidermis through an intracellular pathway.
authors: Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea. ydshderm@yuhs.ac
authors: Sang Eun
authors: SE
authors: Lee
authors: Ki Ju
authors: KJ
authors: Choi
authors: Gopinathan K
authors: GK
authors: Menon
authors: Hyun Jung
authors: HJ
authors: Kim
authors: Eung Ho
authors: EH
authors: Choi
authors: Sung Ku
authors: SK
authors: Ahn
authors: Seung Hun
authors: SH
authors: Lee
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D004058:Diffusion; D016503:Drug Delivery Systems / Q000295:instrumentation / Q000379:methods*; D004817:Epidermis / Q000378:metabolism* / Q000648:ultrastructure; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007811:Lanthanum / Q000008:administration & dosage / Q000493:pharmacokinetics*; D051379:Mice; D008812:Mice, Hairless; D046529:Microscopy, Electron, Transmission; D053758:Nanoparticles; D019301:Oleic Acid / Q000493:pharmacokinetics; D014465:Ultrasonics
chemical_list: D005290:Ferric Compounds; C000499:ferric oxide; D019301:Oleic Acid; C016534:lanthanide nitrate; D007811:Lanthanum